Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tania Azam

Showing results (31-40 of 52) with videos related to

Pageof 6
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|March 2, 2019
Interleukin-37 monomer is the active form for reducing innate immunityElan Z Eisenmesser, Adrian Gottschlich, Jasmina S Redzic, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 17, 2010
Paradoxical effects of constitutive human IL-32{gamma} in transgenic mice during experimental colitisJida Choi, Suyoung Bae, Jaewoo Hong, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 6, 2006
Peripheral blood neutrophil activation patterns are associated with pulmonary inflammatory responses to lipopolysaccharide in humansEdward Abraham, Jerry A Nick, Tania Azam, et al.
The Journal of Biological Chemistry|April 6, 2021
A novel anti-human IL-1R7 antibody reduces IL-18-mediated inflammatory signalingSuzhao Li, Liqiong Jiang, Karsten Beckmann, et al.
Plos Medicine|August 15, 2006
Mycobacterium tuberculosis induces interleukin-32 production through a caspase- 1/IL-18/interferon-gamma-dependent mechanismMihai G Netea, Tania Azam, Eli C Lewis, et al.
Immunology|September 6, 2008
Identification of the most active interleukin-32 isoformJi-Da Choi, Su-Young Bae, Jae-Woo Hong, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 9, 2012
IL-38 binds to the IL-36 receptor and has biological effects on immune cells similar to IL-36 receptor antagonistFrank L van de Veerdonk, Angela K Stoeckman, Gouping Wu, et al.
Inflammatory Bowel Diseases|July 10, 2013
Alpha-1-antitrypsin therapy ameliorates acute colitis and chronic murine ileitisColm B Collins, Carol M Aherne, Stefan F Ehrentraut, et al.
Cytokine|February 22, 2008
Unique expression of a small IL-32 protein in the Jurkat leukemic T cell lineNa-Young Ko, Sung-Ho Chang, Jun-Ho Lee, et al.
The Journal of Biological Chemistry|July 15, 2018
Interleukin-37 treatment of mice with metabolic syndrome improves insulin sensitivity and reduces pro-inflammatory cytokine production in adipose tissueDov B Ballak, Suzhao Li, Giulio Cavalli, et al.
Pageof 6

Showing results (31-40 of 52) with videos related to

Sort By:
Pageof 6
Proceedings of the National Academy of Sciences of the United States of America|March 2, 2019
Interleukin-37 monomer is the active form for reducing innate immunityElan Z Eisenmesser, Adrian Gottschlich, Jasmina S Redzic, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 17, 2010
Paradoxical effects of constitutive human IL-32{gamma} in transgenic mice during experimental colitisJida Choi, Suyoung Bae, Jaewoo Hong, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 6, 2006
Peripheral blood neutrophil activation patterns are associated with pulmonary inflammatory responses to lipopolysaccharide in humansEdward Abraham, Jerry A Nick, Tania Azam, et al.
The Journal of Biological Chemistry|April 6, 2021
A novel anti-human IL-1R7 antibody reduces IL-18-mediated inflammatory signalingSuzhao Li, Liqiong Jiang, Karsten Beckmann, et al.
Plos Medicine|August 15, 2006
Mycobacterium tuberculosis induces interleukin-32 production through a caspase- 1/IL-18/interferon-gamma-dependent mechanismMihai G Netea, Tania Azam, Eli C Lewis, et al.
Immunology|September 6, 2008
Identification of the most active interleukin-32 isoformJi-Da Choi, Su-Young Bae, Jae-Woo Hong, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 9, 2012
IL-38 binds to the IL-36 receptor and has biological effects on immune cells similar to IL-36 receptor antagonistFrank L van de Veerdonk, Angela K Stoeckman, Gouping Wu, et al.
Inflammatory Bowel Diseases|July 10, 2013
Alpha-1-antitrypsin therapy ameliorates acute colitis and chronic murine ileitisColm B Collins, Carol M Aherne, Stefan F Ehrentraut, et al.
Cytokine|February 22, 2008
Unique expression of a small IL-32 protein in the Jurkat leukemic T cell lineNa-Young Ko, Sung-Ho Chang, Jun-Ho Lee, et al.
The Journal of Biological Chemistry|July 15, 2018
Interleukin-37 treatment of mice with metabolic syndrome improves insulin sensitivity and reduces pro-inflammatory cytokine production in adipose tissueDov B Ballak, Suzhao Li, Giulio Cavalli, et al.
Pageof 6